These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24582769)

  • 1. Atorvastatin inhibits CXCR7 induction to reduce macrophage migration.
    Ma W; Liu Y; Wang C; Zhang L; Crocker L; Shen J
    Biochem Pharmacol; 2014 May; 89(1):99-108. PubMed ID: 24582769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of C-X-C chemokine receptor type 7 (CXCR7) switches stromal cell-derived factor-1 (SDF-1) signaling and phagocytic activity in macrophages linked to atherosclerosis.
    Ma W; Liu Y; Ellison N; Shen J
    J Biol Chem; 2013 May; 288(22):15481-94. PubMed ID: 23599431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atorvastatin reduces long pentraxin 3 expression in vascular cells by inhibiting protein geranylgeranylation.
    Baetta R; Lento S; Ghilardi S; Barbati E; Corsini A; Tremoli E; Banfi C
    Vascul Pharmacol; 2015; 67-69():38-47. PubMed ID: 25849951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atorvastatin inhibits ABCA1 expression and cholesterol efflux in THP-1 macrophages by an LXR-dependent pathway.
    Qiu G; Hill JS
    J Cardiovasc Pharmacol; 2008 Apr; 51(4):388-95. PubMed ID: 18427282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atorvastatin inhibits angiotensin-converting enzyme induction in differentiating human macrophages.
    Saijonmaa O; Nyman T; Fyhrquist F
    Am J Physiol Heart Circ Physiol; 2007 Apr; 292(4):H1917-21. PubMed ID: 17158648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of bFGF-induced smooth muscle cell proliferation and endothelin receptor mRNA expression by mevastatin and atorvastatin.
    Xu CB; Stenman E; Edvinsson L
    Biochem Pharmacol; 2002 Aug; 64(3):497-505. PubMed ID: 12147302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparisons of effects of statins (atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjects.
    Schaefer EJ; McNamara JR; Tayler T; Daly JA; Gleason JL; Seman LJ; Ferrari A; Rubenstein JJ
    Am J Cardiol; 2004 Jan; 93(1):31-9. PubMed ID: 14697462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of atorvastatin, fluvastatin, pravastatin, and simvastatin on endothelial function, lipid peroxidation, and aortic atherosclerosis in hypercholesterolemic rabbits].
    Jorge PA; Almeida EA; Ozaki MR; Jorge M; Carneiro A
    Arq Bras Cardiol; 2005 Apr; 84(4):314-9. PubMed ID: 15880205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atorvastatin decreases lipoprotein lipase and endothelial lipase expression in human THP-1 macrophages.
    Qiu G; Hill JS
    J Lipid Res; 2007 Oct; 48(10):2112-22. PubMed ID: 17644777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin-mediated inhibition of cholesterol synthesis induces cytoprotective autophagy in human leukemic cells.
    Vilimanovich U; Bosnjak M; Bogdanovic A; Markovic I; Isakovic A; Kravic-Stevovic T; Mircic A; Trajkovic V; Bumbasirevic V
    Eur J Pharmacol; 2015 Oct; 765():415-28. PubMed ID: 26358205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High doses of atorvastatin and simvastatin induce key enzymes involved in VLDL production.
    Roglans N; Verd JC; Peris C; Alegret M; Vázquez M; Adzet T; Díaz C; Hernández G; Laguna JC; Sánchez RM
    Lipids; 2002 May; 37(5):445-54. PubMed ID: 12056585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of development of experimental aortic abdominal aneurysm in rat model by atorvastatin through inhibition of macrophage migration.
    Shiraya S; Miyake T; Aoki M; Yoshikazu F; Ohgi S; Nishimura M; Ogihara T; Morishita R
    Atherosclerosis; 2009 Jan; 202(1):34-40. PubMed ID: 18482727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase.
    Wassmann S; Laufs U; Bäumer AT; Müller K; Konkol C; Sauer H; Böhm M; Nickenig G
    Mol Pharmacol; 2001 Mar; 59(3):646-54. PubMed ID: 11179461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins upregulate cystathionine γ-lyase transcription and H2S generation via activating Akt signaling in macrophage.
    Xu Y; Du HP; Li J; Xu R; Wang YL; You SJ; Liu H; Wang F; Cao YJ; Liu CF; Hu LF
    Pharmacol Res; 2014 Sep; 87():18-25. PubMed ID: 24951966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleiotropic effects of statins in atherosclerosis and diabetes.
    Bellosta S; Ferri N; Arnaboldi L; Bernini F; Paoletti R; Corsini A
    Diabetes Care; 2000 Apr; 23 Suppl 2():B72-8. PubMed ID: 10860194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of myogenic differentiation by SDF-1 via CXCR4 and CXCR7 receptors.
    Melchionna R; Di Carlo A; De Mori R; Cappuzzello C; Barberi L; Musarò A; Cencioni C; Fujii N; Tamamura H; Crescenzi M; Capogrossi MC; Napolitano M; Germani A
    Muscle Nerve; 2010 Jun; 41(6):828-35. PubMed ID: 20151462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of platelet cytosolic phospholipase A2 activity by atorvastatin and simvastatin: biochemical regulatory mechanisms.
    Moscardó A; Vallés J; Latorre A; Madrid I; Santos MT
    Thromb Res; 2013 Apr; 131(4):e154-9. PubMed ID: 23352311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germ cell migration in zebrafish is dependent on HMGCoA reductase activity and prenylation.
    Thorpe JL; Doitsidou M; Ho SY; Raz E; Farber SA
    Dev Cell; 2004 Feb; 6(2):295-302. PubMed ID: 14960282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atorvastatin and simvastatin, but not pravastatin, up-regulate LPS-induced MMP-9 expression in macrophages by regulating phosphorylation of ERK and CREB.
    Lee DK; Park EJ; Kim EK; Jin J; Kim JS; Shin IJ; Kim BY; Lee H; Kim DE
    Cell Physiol Biochem; 2012; 30(3):499-511. PubMed ID: 22814256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin-induced expression of decay-accelerating factor protects vascular endothelium against complement-mediated injury.
    Mason JC; Ahmed Z; Mankoff R; Lidington EA; Ahmad S; Bhatia V; Kinderlerer A; Randi AM; Haskard DO
    Circ Res; 2002 Oct; 91(8):696-703. PubMed ID: 12386146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.